Literature DB >> 6208308

Identification of the principal T lymphocyte-stimulating antigens of Pseudomonas aeruginosa.

M J Parmely, B H Iglewski, R T Horvat.   

Abstract

To aid in understanding the role of cellular immunity in limiting Pseudomonas aeruginosa infections, we have identified some of the principal antigens of the organism that are recognized by human T cells. Clones of T cells were selected in such a manner that they would provide information not only about the identity of Pseudomonas antigens, but also the T cell repertoires of immune donors. Most clones were found to be specific for Pseudomonas alkaline protease (AP). Such clones could be physically isolated by selecting with crude Pseudomonas antigens or purified AP. In either case, their fine specificities were the same when tested against a panel of Pseudomonas antigens. The conclusion that AP is the principal immunogen for many donors was confirmed by measuring the absolute frequencies of proliferating T cells committed to AP and all other Pseudomonas antigens. Frequencies of AP-specific clones (1.5-2.7 X 10(-5] were comparable to those from the same donors that were specific for all secreted Pseudomonas antigens (1.3-6.0 X 10(-5]. These results provide a model system for studying human T cell-mediated immunity to bacteria by identifying discrete antigens and measuring the repertoire diversities of cells responding to them.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208308      PMCID: PMC2187495          DOI: 10.1084/jem.160.5.1338

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  A new ultrasensitive method for the determination of proteolytic activity.

Authors:  H Rinderknecht; M C Geokas; P Silverman; B J Haverback
Journal:  Clin Chim Acta       Date:  1968-08       Impact factor: 3.786

2.  Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.

Authors:  P V Liu; H Hsieh
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

3.  Corneal ulcers caused by protease and elastase from Pseudomonas aeruginosa.

Authors:  K Kawaharajo; C Abe; J Y Homma; M Kawano; E Goto
Journal:  Jpn J Exp Med       Date:  1974-10

4.  Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

5.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

6.  Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa.

Authors:  K Kawaharajo; J Y Homma
Journal:  Jpn J Exp Med       Date:  1975-12

7.  Pathogenesis of corneal damage from pseudomonas exotoxin A.

Authors:  B H Iglewski; R P Burns; I K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-01       Impact factor: 4.799

8.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Physicochemical fractionation of extracellular cornea-damaging proteases of Pseudomonas aeruginosa.

Authors:  A S Kreger; O K Griffin
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more
  10 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

3.  Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.

Authors:  H Müller; C Kettelhack; M Kettelhack; H G Sonntag; G Keilich; R Brossmer; J Richards; V Kinzel; E Bäuerlein; H Pech
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

4.  IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Authors:  Gregory P Priebe; Rebecca L Walsh; Terra A Cederroth; Akinobu Kamei; Yamara S Coutinho-Sledge; Joanna B Goldberg; Gerald B Pier
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin.

Authors:  R T Horvat; M Clabaugh; C Duval-Jobe; M J Parmely
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 7.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

8.  Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.

Authors:  T G Theander; A Kharazmi; B K Pedersen; L D Christensen; N Tvede; L K Poulsen; N Odum; M Svenson; K Bendtzen
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

9.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

10.  Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.

Authors:  C H Mody; D E Buser; R M Syme; D E Woods
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.